Lamivudine-resistant rtL180M and rtM204I/V are persistently dominant during combination rescue therapy with entecavir and adefovir for hepatitis B

Adefovir (ADV) sequential monotherapy was included in the 2005 Asia-Pacific guidelines for the management of patients with lamivudine (LAM) resistance. However, following the development of ADV resistance, the proportion of resistant variants during combined rescue therapy with ADV and entecavir (ET...

全面介紹

Na minha lista:
書目詳細資料
發表在:Exp Ther Med
Main Authors: WANG, YANG, LIU, SHUANG, CHEN, YU, ZHENG, SUJUN, ZHOU, LI, LU, FENGMIN, DUAN, ZHONGPING
格式: Artigo
語言:Inglês
出版: D.A. Spandidos 2016
主題:
Articles
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC4888018/
https://ncbi.nlm.nih.gov/pubmed/27313669
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2016.3230
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍